DexCom, Inc. (NASDAQ:DXCM) today announced that Terry Gregg, CEO, and Kevin Sayer, President, will hold a conference call to discuss FDA’s approval of the company’s G4 PLATINUM continuous glucose monitoring system starting at 4:30 p.m. (Eastern Time) on Monday, October 8, 2012. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor relations, events and webcast section, and will be archived for future reference. To listen to the conference call, please dial 1 (888) 771-4371 (US/Canada) or 1 (847) 585-4405 (International) and use the confirmation number "33515973" approximately five minutes prior to the start time. About DexCom, Inc. DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients with diabetes and by healthcare providers in the hospital.